SR‐A3 Promotes USP18‐Mediated deISGylation of STING to Protect Against Myocardial Ischemia‐Reperfusion Injury
Open Access
- 17 August 2026
- journal article
- Published by Wiley in Advanced Science
- Vol. 13 (62)
Abstract
Acute myocardial infarction (MI) is a leading cause of mortality worldwide. Although reperfusion restores coronary blood flow, it paradoxically induces secondary injury that limits therapeutic benefits, and effective interventions for myocardial ischemia/reperfusion injury (MI/RI) remain lacking. Here, we identify scavenger receptor class A member 3 (SR‐A3) as a previously unrecognized cardioprotective factor that plays a central regulatory role in ischemic injury. SR‐A3 was significantly downregulated in myocardial tissues from MI/RI patients. Global or cardiomyocyte‐specific deletion of SR‐A3 exacerbated MI/RI‐induced cardiac damage, whereas AAV9‐mediated overexpression alleviated myocardial injury and improved cardiac function. Notably, SR‐A3 expression in cardiomyocytes underwent the most dramatic reduction upon I/R stress, underscoring its critical role in the injured myocardium. Mechanistically, SR‐A3 interacts with ubiquitin‐specific peptidase 18 (USP18) to suppress interferon‐stimulated gene 15 (ISG15)‐dependent ISGylation, thereby negatively regulating activation of the STING signaling pathway and its downstream innate immune inflammatory cascades. Treatment with Selonsertib, an ASK1 inhibitor that increased USP18 abundance in our MI/RI model, recapitulated the cardioprotective effects, highlighting the translational potential of targeting this signaling axis. Collectively, our findings uncover a novel SR‐A3/USP18/ISG15/STING regulatory pathway governing innate immune activation in MI/RI and position SR‐A3 as a promising therapeutic target for ischemic heart disease.Keywords
Funding Information
- National Natural Science Foundation of China (82270479)
- National Natural Science Foundation of China (82270479)
- National Natural Science Foundation of China (82501040)
- National Natural Science Foundation of China (U25C2004)
- National Natural Science Foundation of China (HY2021‐1)
- Natural Science Foundation of Beijing Municipality (7242084)
- National Natural Science Foundation of China (82270479)
- National Natural Science Foundation of China (82270479)
- National Natural Science Foundation of China (82501040)
- China Postdoctoral Science Foundation (2025M771442)
- National Natural Science Foundation of China (82270479)
- National Natural Science Foundation of China (82270479)
- National Natural Science Foundation of China (82501040)
- National Natural Science Foundation of China (82270479)
- National Natural Science Foundation of China (82270479)
- National Natural Science Foundation of China (82501040)
- National Natural Science Foundation of China (82270479)
- National Natural Science Foundation of China (82501040)
This publication has 27 references indexed in Scilit:
- Regulated cell death in acute myocardial infarction: Molecular mechanisms and therapeutic implicationsAgeing Research Reviews, 2024
- Type I interferon regulation by USP18 is a key vulnerability in canceriScience, 2024
- Regulated cell death in myocardial ischemia–reperfusion injuryTrends in Endocrinology & Metabolism, 2023
- Regulation of STING activity in DNA sensing by ISG15 modificationCell Reports, 2023
- The potential role and mechanism of circRNAs in foam cell formationNon-coding RNA Research, 2023
- Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicityCell, 2023
- Small molecule STING inhibition improves myocardial infarction remodelingLife Sciences, 2022
- Recognition of lipoproteins by scavenger receptor class A membersJournal of Biological Chemistry, 2021
- The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapyActa Pharmaceutica Sinica B, 2021
- Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trialsJournal of Hepatology, 2020